- 5Y
- +80.79%
- $10K became
- $18,079
JNJ vs PFE
Total return with dividends reinvested · 5Y
- 5Y
- -9.44%
- $10K became
- $9,056
Return and risk 5Y
| Ticker | $10K became | Total | Per year | Volatility | Worst drop | Off high now | Best year | Worst year | Years up | Corr. with JNJ |
|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | $18,079 | +80.79% | +12.60% | 17.9% | -18.42% | -7.42% | +48.11% 2025 | -9.37% 2023 | 50% | — |
| PFE | $9,056 | -9.44% | -1.97% | 25.4% | -58.87% | -36.77% | +0.50% 2025 | -41.22% 2023 | 25% | 0.41 |
- $10K became
- $18,079
- Total
- +80.79%
- Per year
- +12.60%
- Volatility
- 17.9%
- Worst drop
- -18.42%
- Off high now
- -7.42%
- Best year
- +48.11% 2025
- Worst year
- -9.37% 2023
- $10K became
- $9,056
- Total
- -9.44%
- Per year
- -1.97%
- Volatility
- 25.4%
- Worst drop
- -58.87%
- Off high now
- -36.77%
- Best year
- +0.50% 2025
- Worst year
- -41.22% 2023
Per year is the compound annual growth rate and needs a year of history. Volatility is the yearly spread of daily returns. Best and worst years count full calendar years only.
Drawdown from peak 5Y
Correlation of daily returns
1 moves together, 0 unrelated, negative moves opposite. Lower correlation means more diversification.
Trailing returns up to 5 years
| Ticker | 1Y | 2Y | 3Y | 5Y |
|---|---|---|---|---|
| JNJ | — | — | — | — |
| PFE | — | — | — | — |
Calendar-year returns best each year in bold
| Year | JNJ | PFE |
|---|---|---|
| No full years in this range yet. | ||
More comparisons
About this comparison
Johnson & Johnson (JNJ) vs Pfizer Inc. (PFE) total return over 5Y: JNJ +80.79%, PFE -9.44%. Regime JNJ BEAR. As of Oct 21, 2026. Research only.
Johnson & Johnson (JNJ) posted a total‑return gain of +83.7% over the past five years, while Pfizer (PFE) lagged with a ‑6.3% return in the same window. The divergence reflects JNJ’s broader product mix and steady dividend yield versus PFE’s recent earnings pressure and higher payout ratio. JNJ closed at $255.6 on 2026‑10‑16 (Friday), up 0.90% intraday. The overlay’s directional signal is SELL (score ‑5) in a BEAR market regime (13‑day). Fundamentals show a P/E of 38.75, ROIC 20.39%, and a 2.07% dividend yield. The stock sits in the Balanced archetype; readers can open the JNJ page for full overlay methodology. PFE closed at $29.58 on 2026‑10‑16 (Friday), up 0.48%. The signal is BUY (score 5) within a BULL regime (6‑day). With a P/E of 39.09, ROIC 10.84% and a 5.81% dividend yield, the ticker is classified as a Dividend Compounder. View the PFE page for complete overlay details.
What does the JNJ vs PFE overlay show?
LOPJLB overlays JNJ vs PFE as total return (dividends and splits) from the first adjusted close in the selected 5Y window. Each path starts at 0% so you can read relative holding performance, not raw tape price.
Is this holding return or tape close?
Holding return. The series uses split- and dividend-adjusted close (Yahoo-style backward adjustment) when dividend coverage is sufficient, otherwise it falls back to tape close. Candles and technical overlays on /chart stay tape.
Which windows are public?
Public visitors can share 1M, 3M, 6M, YTD, 1Y, and 5Y. MAX is Research+. Direction and regime in the table follow the desk ladder: SPY25 on Free, full book on Essential+.
How do I read the drawdown, period, and annual tables?
Drawdowns are current and worst peak-to-trough on the visible range. Periods are calendar lookbacks (1Y / 2Y / 3Y / 5Y, plus 10Y on MAX) from the last bar. Annual is calendar-year holding return, with the latest year labeled YTD.
How has JNJ vs PFE performed on a normalized basis?
JNJ vs PFE holding-return overlay: 5Y JNJ +80.79% · PFE -9.44%; worst drawdown JNJ -18.42% · PFE -58.87%; YTD JNJ +26.33% · PFE +24.81%. Numbers update from the live compare-series book.
Is ticker compare investment advice?
No. The overlay is research context only — not a recommendation to buy or sell any security.